PARLODEL Drug Patent Profile
✉ Email this page to a colleague
When do Parlodel patents expire, and when can generic versions of Parlodel launch?
Parlodel is a drug marketed by Ss Pharma and is included in one NDA.
The generic ingredient in PARLODEL is bromocriptine mesylate. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the bromocriptine mesylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Parlodel
A generic version of PARLODEL was approved as bromocriptine mesylate by SANDOZ on January 13th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PARLODEL?
- What are the global sales for PARLODEL?
- What is Average Wholesale Price for PARLODEL?
Summary for PARLODEL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 54 |
Clinical Trials: | 10 |
Patent Applications: | 3,142 |
Drug Prices: | Drug price information for PARLODEL |
What excipients (inactive ingredients) are in PARLODEL? | PARLODEL excipients list |
DailyMed Link: | PARLODEL at DailyMed |
Recent Clinical Trials for PARLODEL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Heart, Lung, and Blood Institute (NHLBI) | Phase 4 |
Dennis McNamara | Phase 4 |
University of California, San Diego | Early Phase 1 |
Pharmacology for PARLODEL
Drug Class | Ergot Derivative |
US Patents and Regulatory Information for PARLODEL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ss Pharma | PARLODEL | bromocriptine mesylate | CAPSULE;ORAL | 017962-002 | Mar 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Ss Pharma | PARLODEL | bromocriptine mesylate | TABLET;ORAL | 017962-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PARLODEL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ss Pharma | PARLODEL | bromocriptine mesylate | CAPSULE;ORAL | 017962-002 | Mar 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Ss Pharma | PARLODEL | bromocriptine mesylate | TABLET;ORAL | 017962-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Ss Pharma | PARLODEL | bromocriptine mesylate | TABLET;ORAL | 017962-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PARLODEL
See the table below for patents covering PARLODEL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Finland | 49035 | ⤷ Sign Up | |
Yugoslavia | 133669 | ⤷ Sign Up | |
Spain | 367828 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |